Type D lymphomatoid papulosis with pityriasis lichenoides et varioliformis acuta-like features in a child with parvovirus infection: a controversial diagnosis in the spectrum of lymphoid proliferations: case report and literature reviewArticle Published on 2022-10-282022-11-16 Journal: Italian Journal of Pediatrics [Category] COVID19(2023년), SARS, 치료기술, [키워드] Administered Alanine antigenic Aspartate aminotransferase Bilirubin C-reactive protein Case report CD8+/CD30+ cells children clinical response clinical suspicion Critical cytokine profile Cytokines Department Diagnosis differential diagnosis discharged disease disorder Emergency erythematous feature Fever histological history Hospitalized IFN-γ IL-10 IL-6 immunoglobulin M infectious agent infiltration introduced Laboratory test lesion lesions limits literature review lymphoid lymphomatoid Lymphomatoid papulosis lymphoproliferative Lymphoproliferative cutaneous disorders marker mechanism monoclonal morphologically necrotic Parvovirus parvovirus B19 pathogenic Perspective phenotype pityriasis lichenoides et varioliformis acuta. polymerase chain reaction positive response proliferation Rash recorded regions reported representing returned SARS-CoV-2 antigen separated skin lesions steroid Support Symptom systemic corticosteroid T-cell receptor Therapies Treatment Type Type D [DOI] 10.1186/s13052-022-01371-x PMC 바로가기
Reactivation of EBV and CMV in Severe COVID-19-Epiphenomena or Trigger of Hyperinflammation in Need of Treatment? A Large Case Series of Critically ill Patients심각한 COVID-19-Epiphenomena에서 EBV 및 CMV의 재활성화 또는 치료가 필요한 Hyperinflammation의 트리거? 중환자의 대규모 사례 시리즈Article Published on 2022-09-012022-09-11 Journal: Journal of Intensive Care Medicine [Category] 치료기술, 치료제, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 analyzed ARDS Chain Reaction Characteristics Clinical deterioration CMV cohort study comparable connection control group coronavirus Corticosteroid Course COVID-19 Critically ill Critically ill patient critically ill patients cytomegalovirus decrease described Diagnosis disease EBV Epstein-Barr virus Follow-up analysis Ganciclovir high risk hyperinflammation ICU in viral incidence increased mortality initiation of treatment intensive care intensive care unit majority Non-COVID-19 non-COVID-19 patient Non-COVID-19 patients outcome Patient polymerase chain polymerase chain reaction Reactivation remains uncertain retrospective rituximab SARS-CoV-2 screened Sepsis sepsis patient Sery severe acute respiratory syndrome Coronavirus severe COVID-19 single-center survived systemic corticosteroid treated Treatment Trigger Viral load viral reactivation virus with COVID-19 [DOI] 10.1177/08850666211053990 PMC 바로가기 [Article Type] Article
Intratympanic injection of dexamethasone for management of labyrinthitis associated with COVID-19 disease resistant casesResearch article Published on 2022-09-012022-10-05 Journal: Annals of Medicine and Surgery [Category] 진단, 치료제, [키워드] assessment Combined complete recovery corticosteroid therapy COVID 19 COVID-19 Dexamethasone disease Efficacy evaluate hearing loss injection Labyrinthitis management objective oral steroid outcome Patient patients Prednisolone Result systemic corticosteroid treated Treatment vestibular disorder was done with COVID-19 [DOI] 10.1016/j.amsu.2022.104429 [Article Type] Research article
Major candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID studyObservational Study Published on 2022-07-012022-10-04 Journal: Intensive care medicine [Category] 임상, [키워드] Administered administration affected age Analysis assessment Bacterial baseline benefit Care clinically Corticosteroid corticosteroid treatment Corticosteroids covariate COVID-19 COVID-19 patient Critically ill Critically ill patient Dexamethasone dosage dose doses of corticosteroid early administration Evidence failure higher risk hospitalisation ICU ICU admission ICUs Illness severity in-hospital mortality increased risk Inflammation information intensive care interaction term Invasive mechanical ventilation investigated Laboratory lower risk Major mechanical ventilation Modification Mortality multivariable analysis no effect nosocomial Observational cohort study organ damage Patient patients with COVID-19 performed personalised Pneumonia potential benefit Primary outcome Protective receiving severe coronavirus disease severity Significant SOFA Spanish steroid subgroup subgroups subgroups of patient symptom onset systemic corticosteroid Treatment use of corticosteroid variable with COVID-19 [DOI] 10.1007/s00134-022-06726-w PMC 바로가기 [Article Type] Observational Study
Effectiveness of Systemic Corticosteroids Therapy for Nonsevere Patients With COVID-19: A Multicenter, Retrospective, Longitudinal Cohort StudyResearch article Published on 2022-05-012022-10-05 Journal: Value in health : the journal of the International [Category] COVID19(2023년), SARS, 치료제, [키워드] 95% confidence interval adjusted hazard ratio all-cause mortality Analysis association clinical evidence clinical outcomes clinically Cohort conducted Corticosteroid Corticosteroids COVID-19 Cox model Disease progression dose Efficacy elevated evaluate the effect Follow-up Hospitalization longitudinal Mortality multicenter Multiple linear regression objective outcomes Patient patients with COVID-19 Probability progression propensity score analysis propensity score matching Result retrospective cohort study risk SCU significantly systemic systemic corticosteroid systemic corticosteroids Treatment were used [DOI] 10.1016/j.jval.2021.12.013 [Article Type] Research article
Steroid therapy and antiviral treatment in SARS-CoV-2 pneumonia: clinical contexts and indicationsSARS-CoV-2 폐렴에서 스테로이드 요법 및 항바이러스 치료: 임상적 맥락 및 적응증Review Published on 2022-04-012022-09-11 Journal: Revista española de quimioterapia : publicación [Category] COVID19(2023년), SARS, 치료제, [키워드] 28-day mortality Antiviral treatment benefit Clinical improvement clinical trial complications Corticosteroids Critically ill Critically ill patient critically ill patients decrease Dexamethasone Disease progression drug Effectiveness Fluid management group Health Organization higher risk include indication measure mechanical ventilation Meta-analysis Mortality oxygen Oxygen therapy Patient patients with COVID-19 per day performed Placebo RECOVERY trial reduction in Remdesivir requiring supplemental oxygen routine care SARS-CoV-2 Standard of care steroid therapy subgroup analysis supplemental oxygen supportive care systemic corticosteroid systemic corticosteroids Trial WHO with COVID-19 World Health Organization [DOI] 10.37201/req/s01.13.2022 PMC 바로가기 [Article Type] Review
Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or extracorporeal membrane oxygenation: an exploratory, randomised, placebo-controlled trialClinical Trial Published on 2022-04-012022-10-04 Journal: The Lancet. Respiratory Medicine [Category] COVID19(2023년), SARS, 임상, 치료법, [키워드] 1:1 A significant reduction all-cause mortality assigned Baricitinib baseline Blood clots Brazil cardiovascular event Care Cohort Combination company conducted Corticosteroids Critically ill death died double-blind duration of hospitalisation Efficacy efficacy analysis Efficacy and safety Endpoint enrolled evaluate event exploratory extracorporeal membrane oxygenation hazard ratio hospital hospitalised hospitalised patient infections inhibitor intention-to-treat population Invasive mechanical ventilation investigator Janus kinase laboratory-confirmed SARS-CoV-2 infection less Lilly membrane Mortality not differ participant Participants Patient Phase 3 phase 3 trial Placebo placebo-controlled trial placebo-treated participant prevented randomised Randomly receiving reduced reduction Registered risk reduction safety analysis safety population SARS-COV-2 infection selective severely ill patient shown significantly significantly shorter Standard Standard of care Study design study group study population systemic corticosteroid the placebo group Time to recovery Treatment treatment group treatment groups Trial USA ventilator-free day Ventilator-free days was done with COVID-19 [DOI] 10.1016/S2213-2600(22)00006-6 PMC 바로가기 [Article Type] Clinical Trial
Can FeNO be a biomarker in the post-COVID-19 patients monitoring?FeNO는 코로나19 이후 환자 모니터링에서 바이오마커가 될 수 있습니까?Article Published on 2022-03-012022-09-11 Journal: Respiratory medicine [Category] MERS, SARS, 바이오마커, [키워드] 95% CI Asthma Biomarker bronchial asthma Can clinical manifestation clinical manifestations Consistency control group Corticosteroid Corticosteroids COVID-19 disease onset enrolled FeNO healthy subject healthy subjects healthy volunteer Hospitalized Hypothesis Inflammatory mean difference men nitric oxide Patient post-COVID-19 post-COVID-19 patient Post-COVID-19 patients reported statistically significant syndrome systemic corticosteroid systemic corticosteroids the mean treated women [DOI] 10.1016/j.rmed.2022.106745 PMC 바로가기 [Article Type] Article
Pattern of medication utilization in hospitalized patients with COVID-19 in three District Headquarters Hospitals in the Punjab province of PakistanResearch article Published on 2022-03-012022-10-05 Journal: Exploratory Research in Clinical and Social Pharmacy [Category] 신약개발, 치료제, [키워드] addition Administered Antibiotics Anticoagulant antithrombotic therapy Clinical characteristics Clinical severity Cohort concerning conducted Corticosteroid Corticosteroids COVID-19 COVID-19 severity described Dexamethasone died discharged District enrolled evaluate finding heparin hospitalized patient medication medications Mild mild illness moderate multicenter Pakistan Patient patients patients hospitalized pattern Prevalence provided Repurposed drug retrospective SARS-CoV-2 steroid stratified systemic corticosteroid therapeutic option Treatment with COVID-19 [DOI] 10.1016/j.rcsop.2021.100101 [Article Type] Research article
Case Report: Rowell Syndrome–Like Flare of Cutaneous Lupus Erythematosus Following COVID-19 InfectionMedicine Published on 2022-02-142022-10-31 Journal: Frontiers in Medicine [Category] COVID-19, [키워드] acute respiratory syndrome anti-SARS-CoV-2 vaccine Antibiotics antibodies association Autoimmune caused characterized Chest Clinical course Clinical symptoms coronavirus Corticosteroid COVID-19 COVID-19 infection COVID-19 pandemic cutaneous lupus erythematosus cutaneous manifestation defined Dermatology described Diagnosis diagnostic diffuse disease disorders erythema multiforme erythema multiforme-like exacerbating flare histologic Hydroxychloroquine increased risk increasingly Infection Inflammatory lesion lesions medications Nasopharyngeal swab nonspecific Patient positive reported routine tests Rowell syndrome SARS-CoV-2 SARS-COV-2 infection subacute cutaneous lupus erythematosus syndrome systemic corticosteroid the disease the SARS-CoV-2 therapeutic treated variant was related worsening [DOI] 10.3389/fmed.2022.815743 PMC 바로가기 [Article Type] Medicine